Algodon Wine Estates

Book Now

AmpliMed Secures $8.5 Million in Additional Series B Financing

Oncology Drug Development Company to Use Funds to Achieve Milestones in Clinical Development

Source: FierceBiotech
By: Maureen Martino

TUCSON, Ariz.-- AmpliMed® Corporation today announced a second closing of its Series B Preferred private placement of $8.5 million, raising the total invested in the round to approximately $14.6 million. The Series B was led by Biotech Insight Ventures and included InvestBio Ventures, Valley Ventures and Solstice Capital, all of whom were previous investors. To date, AmpliMed has raised more than $24 million in financing.

External Link:

Reservations +54 (11) 3530 7777Click here for suite availability & hotel reservations Special PromotionsExciting packages at Algodon Mansion Contact UsSuite rate monthly specials. Newsletter sign-up.
Print Email
More Algodon Properties